Complete Remission in Newly Diagnosed Type 1 Diabetes Mellitus Patient

Type 1 diabetes mellitus is a chronic disease affects pancreatic beta cells. Usually it has a life long duration, however, in few cases, it can be transient. We reported a 20 year old male patient who visited the diabetic clinic of Lok Nayak Hospital with classical symptoms of type 1 diabetes mellitus. He was diagnosed with type 1 diabetes on the basis of lab parameters. He was found to be positive for ICA512 and GAD antibodies. Measurement of C-peptide was also done by mixed meal tolerance test. Initially, Insulin was advised to control hyperglycemia. After 2 weeks, he was given 14 infusions of Teplizumab injection, one infusion per day and the same has been repeated after six months. As per clinical judgment, it was assumed that he was not on placebo arm and probably received Teplizumab as investigational product. Teplizumab injection drastically reduces the insulin doses and after some time, his insulin was completely waived off. Complete remission was seen in this patient after treatment with Teplizumab injection. During the 4 years follow-up, this remission is still ongoing in this patient. He had normal fasting and home blood glucose concentration with normal HbA1c without insulin therapy from last 4 years. To keep his blood sugar values under control, patient was also advised regular exercise and a diabetic diet.